Results for "HDA Factbook"
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA Statement on Proposed Tariffs of Pharmaceutical Products
HDA released a statement in response to President Donald J. Trump’s announcement on pledged tariffs for pharmaceuticals.
HDA Statement on Senate Confirmation of Dr. Marty Makary As FDA Commissioner
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Senate’s vote to confirm Dr. Marty Makary as the Food and Drug Administration (FDA) Commissioner.
Greg Drew, RPh, of Value Drug Honored With 2022 Nexus Award for Lifetime Achievement
The HDA Research Foundation honors Greg Drew, RPh, President of Value Drug Company, with the 2022 Nexus Award for Lifetime Achievement. The Nexus Award, the healthcare distribution industry’s highest individual recognition, was presented last night at the 2022 Business and Leadership Conference in Orlando, Fla.